Drug and Alcohol Clinical Services, Hunter New England Health Local Health District, Newcastle, New South Wales, Australia.
School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, 2308, Australia.
Addiction. 2022 Apr;117(4):847-860. doi: 10.1111/add.15663. Epub 2021 Sep 28.
Up to 95% of pregnant women seeking treatment for alcohol and other drug (AOD) use smoke tobacco. Previous reviews indicate few effective smoking cessation treatments for this group. This updated review aimed to identify and measure the efficacy of smoking cessation interventions trialled among pregnant women in AOD treatment settings who smoke tobacco.
A narrative synthesis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Studies involving psychological, behavioural or pharmacological interventions used to treat tobacco use, including electronic nicotine delivery systems, for pregnant women of any age, who smoked tobacco and were seeking/receiving treatment, or in post-treatment recovery for AOD concerns, were reviewed. MEDLINE, PsycINFO, CINAHL, EMBASE and ProQuest databases, grey literature and reference lists were searched, and field experts were contacted for unpublished study data. The Effective Public Health Practice Project tool assessed study quality. The review was pre-registered with PROSPERO no. CRD42018108777.
Seven interventions (two randomised controlled trials, two single-arm pilot studies, two program evaluations and one causal comparative study) treating 875 women were identified. All were United States (US)-based and targeted women with drug dependence, but not alcohol dependence. Three interventions used contingency management, five provided behavioural counselling, and one offered nicotine replacement therapy. All reported reductions in cigarette consumption; one contingency management-based study demonstrated higher abstinence rates compared with controls at treatment-end that were not maintained at follow-up. Four of six studies were rated as methodologically weak and one unpublished study was not rated.
Conclusions about the efficacy of smoking interventions for pregnant women with alcohol and other drug concerns who also smoke tobacco are hindered by the paucity of available data and poor methodological quality of included studies.
高达 95%的寻求酒精和其他药物(AOD)治疗的孕妇吸烟。先前的综述表明,针对这一群体的有效戒烟治疗方法很少。本次更新的综述旨在确定和衡量在 AOD 治疗环境中寻求或接受治疗的吸烟孕妇中试用的戒烟干预措施的效果。
根据系统评价和荟萃分析的首选报告项目声明进行叙述性综合。研究涉及用于治疗烟草使用的心理、行为或药理学干预措施,包括电子烟,针对任何年龄的吸烟且正在寻求/接受治疗的孕妇,或正在接受 AOD 问题治疗后的恢复期的孕妇。检索了 MEDLINE、PsycINFO、CINAHL、EMBASE 和 ProQuest 数据库、灰色文献和参考文献,并联系了领域专家以获取未发表的研究数据。使用有效公共卫生实践项目工具评估了研究质量。该综述已在 PROSPERO 注册,编号为 CRD42018108777。
确定了 7 项干预措施(2 项随机对照试验、2 项单臂试点研究、2 项方案评估和 1 项因果比较研究),共涉及 875 名女性。所有研究均来自美国,针对的是药物依赖但不酗酒的女性。3 项干预措施使用了条件管理,5 项提供了行为咨询,1 项提供了尼古丁替代疗法。所有研究均报告了吸烟量减少;一项基于条件管理的研究表明,与对照组相比,治疗结束时的戒烟率更高,但在随访中并未维持。6 项研究中有 4 项被评为方法学上较弱,1 项未发表的研究未被评级。
由于现有数据的缺乏和纳入研究的方法学质量较差,关于针对同时有酒精和其他药物问题且吸烟的孕妇的吸烟干预措施的效果的结论受到阻碍。